Panagiotis "Panos" Deloukas FMedSci is Professor of Cardiovascular Genomics and Dean for Life Sciences at the William Harvey Research Institute. This institute is a division of Queen Mary University of London (QMUL)'s Barts and the London School of Medicine and Dentistry. He has been an ISI highly cited researcher since 2012 [1] and was elected a fellow of the Academy of Medical Sciences in 2018. [2]
Deloukas received his bachelor's degree in chemistry from the Aristotelian University of Thessaloniki in Greece and his master's degree in microbiology from Paris Diderot University in France. In 1991, he earned his Ph.D. from the Biozentrum University of Basel in Switzerland. He began working at the Sanger Centre in the United Kingdom in 1994, and continued to work there until 2013, when he began working at the William Harvey Research Institute at QMUL. At the Sanger Centre, he worked on the analysis of chromosomes 10 and 20 for the Human Genome Project, followed by a role designing SNP maps of the human genome for the HapMap Project. [1]
Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.
Sir John Edward Sulston was a British biologist and academic who won the Nobel Prize in Physiology or Medicine for his work on the cell lineage and genome of the worm Caenorhabditis elegans in 2002 with his colleagues Sydney Brenner and Robert Horvitz. He was a leader in human genome research and Chair of the Institute for Science, Ethics and Innovation at the University of Manchester. Sulston was in favour of science in the public interest, such as free public access of scientific information and against the patenting of genes and the privatisation of genetic technologies.
Sir Aaron Klug was a Lithuanian-born British biophysicist and chemist. He was a winner of the 1982 Nobel Prize in Chemistry for his development of crystallographic electron microscopy and his structural elucidation of biologically important nucleic acid-protein complexes.
The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.
Sir Peter James Donnelly is an Australian mathematician and Professor of Statistical Science at the University of Oxford, and the CEO of Genomics PLC. He is a specialist in applied probability and has made contributions to coalescent theory. His research group at Oxford has an international reputation for the development of statistical methodology to analyze genetic data.
Dermot P. Kelleher FMedSci is the Dean of the Faculty of Medicine and Vice-President, Health at the University of British Columbia in Vancouver, Canada.
David Haussler is an American bioinformatician known for his work leading the team that assembled the first human genome sequence in the race to complete the Human Genome Project and subsequently for comparative genome analysis that deepens understanding the molecular function and evolution of the genome.
Gilean Alistair Tristram McVean is a professor of statistical genetics at the University of Oxford, director of the Big Data Institute, fellow of Linacre College, Oxford and co-founder and director of Genomics plc. He also co-chaired the 1000 Genomes Project analysis group.
Christopher Carl Goodnow is an immunology researcher and the current Executive Director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the Faculty of Medicine at UNSW Sydney. He holds dual Australian and US citizenship.
Manchanahalli Rangaswamy Satyanarayana Rao known by the abbreviation M. R. S. Rao, is an Indian scientist, born on 21 January 1948 at Mysore, India. He has been awarded the fourth highest civilian award Padma Shri in Science and Engineering category by the Government of India. He was the President of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bangalore, India (2003-2013)
Sir Michael Rudolf Stratton, is a British clinical scientist and the third director of the Wellcome Trust Sanger Institute. He currently heads the Cancer Genome Project and is a leader of the International Cancer Genome Consortium.
Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.
Karen Penelope Steel FRS FMedSci is a British scientist who studies the genetics of deafness, using the mouse as a model to identify the genes involved and to understand the molecular, cellular and physiological mechanisms involved. She is Professor of Sensory Function at the Wolfson Centre for Age-Related Diseases, King's College London. Previously she was Principal Investigator of the Genetics of Deafness research programme at the Wellcome Trust Sanger Institute.
Jack Martin Cuzick is an American-born British academic, director of the Wolfson Institute of Preventive Medicine in London and head of the Centre for Cancer Prevention. He is the John Snow Professor of Epidemiology at the Wolfson Institute, Queen Mary University of London.
Asis Datta is an Indian biochemist, molecular biologist and genetic engineer, known for his research on genetically modified foods and food nutritional security. He was the founding Director of the National Institute of Plant Genome Research and is credited with the discovery of genes that assist in extended preservation of fruits and vegetables. He is a recipient of the Shanti Swarup Bhatnagar Award, the highest Indian award and in the Science category, and was awarded the fourth highest civilian award of the Padma Shri, by the Government of India, in 1999. In 2008, he was included again in the Republic Day Honours list for the third highest civilian honour of the Padma Bhushan.
Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.
Dominic Kwiatkowski is head of the parasites and microbes programme at the Wellcome Sanger Institute in Cambridge and a Professor of Genomics at the University of Oxford. Kwiatkowski applies genomics and computational analysis to problems in infectious disease, with the aim of finding ways to reduce the burden of disease in the developing world.
Nicole Soranzo is an Italian-British senior group leader in human genetics at the Wellcome Sanger Institute, Professor of Human Genetics at the University of Cambridge. She is an internationally recognised Human Geneticist who has focused on the application of cutting edge genomic technologies to study the spectrum of human genetic variation associated with cardio-metabolic and immune diseases. She has led many large-scale discovery efforts including more than 1,000 novel genetic variants associated with cardio-metabolic diseases and their risk factors as well as establishing the HaemGen consortium, which is a worldwide effort to discover genetic determinants of blood cell formation and also interpretation of the downstream consequences of sequence variation through a host of integrative analyses and functional approaches.
Professor Sir Mark Jonathan Caulfield MD, FRCP, FESC, FPharm, FBHS, FMedSci is a British genomic medicine researcher. He is the professor of Clinical Pharmacology at the William Harvey Research Institute in Queen Mary University of London. He was awarded a knighthood in the 2019 Birthday Honours.
Sussan Nourshargh is a British immunologist, pharmacologist, and professor of microvascular pharmaclogy and immunopharmacology. She founded the Centre for Microvascular research at Queen Mary University.